10-110567718-C-A

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBS1BS2

The NM_005445.4(SMC3):​c.-99C>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0171 in 1,451,596 control chromosomes in the GnomAD database, including 278 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.014 ( 21 hom., cov: 34)
Exomes 𝑓: 0.017 ( 257 hom. )

Consequence

SMC3
NM_005445.4 5_prime_UTR

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.201

Publications

1 publications found
Variant links:
Genes affected
SMC3 (HGNC:2468): (structural maintenance of chromosomes 3) This gene belongs to the SMC3 subfamily of SMC proteins. The encoded protein occurs in certain cell types as either an intracellular, nuclear protein or a secreted protein. The nuclear form, known as structural maintenance of chromosomes 3, is a component of the multimeric cohesin complex that holds together sister chromatids during mitosis, enabling proper chromosome segregation. Post-translational modification of the encoded protein by the addition of chondroitin sulfate chains gives rise to the secreted proteoglycan bamacan, an abundant basement membrane protein. [provided by RefSeq, Jul 2008]
SMC3 Gene-Disease associations (from GenCC):
  • Cornelia de Lange syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Cornelia de Lange syndrome 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.014 (2133/152338) while in subpopulation AMR AF = 0.041 (628/15304). AF 95% confidence interval is 0.0384. There are 21 homozygotes in GnomAd4. There are 1067 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High AC in GnomAd4 at 2133 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SMC3NM_005445.4 linkc.-99C>A 5_prime_UTR_variant Exon 1 of 29 ENST00000361804.5 NP_005436.1 Q9UQE7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SMC3ENST00000361804.5 linkc.-99C>A 5_prime_UTR_variant Exon 1 of 29 1 NM_005445.4 ENSP00000354720.5 Q9UQE7

Frequencies

GnomAD3 genomes
AF:
0.0140
AC:
2127
AN:
152220
Hom.:
21
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00328
Gnomad AMI
AF:
0.0461
Gnomad AMR
AF:
0.0408
Gnomad ASJ
AF:
0.0124
Gnomad EAS
AF:
0.00116
Gnomad SAS
AF:
0.0192
Gnomad FIN
AF:
0.00292
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0164
Gnomad OTH
AF:
0.0163
GnomAD4 exome
AF:
0.0174
AC:
22670
AN:
1299258
Hom.:
257
Cov.:
18
AF XY:
0.0176
AC XY:
11473
AN XY:
653032
show subpopulations
African (AFR)
AF:
0.00421
AC:
127
AN:
30136
American (AMR)
AF:
0.0441
AC:
1859
AN:
42176
Ashkenazi Jewish (ASJ)
AF:
0.0171
AC:
415
AN:
24244
East Asian (EAS)
AF:
0.000129
AC:
5
AN:
38720
South Asian (SAS)
AF:
0.0220
AC:
1801
AN:
81724
European-Finnish (FIN)
AF:
0.00558
AC:
288
AN:
51642
Middle Eastern (MID)
AF:
0.0342
AC:
156
AN:
4558
European-Non Finnish (NFE)
AF:
0.0176
AC:
17092
AN:
971420
Other (OTH)
AF:
0.0170
AC:
927
AN:
54638
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1100
2200
3300
4400
5500
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
614
1228
1842
2456
3070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0140
AC:
2133
AN:
152338
Hom.:
21
Cov.:
34
AF XY:
0.0143
AC XY:
1067
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.00327
AC:
136
AN:
41590
American (AMR)
AF:
0.0410
AC:
628
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0124
AC:
43
AN:
3470
East Asian (EAS)
AF:
0.00116
AC:
6
AN:
5172
South Asian (SAS)
AF:
0.0192
AC:
93
AN:
4834
European-Finnish (FIN)
AF:
0.00292
AC:
31
AN:
10630
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.0164
AC:
1113
AN:
68018
Other (OTH)
AF:
0.0166
AC:
35
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
112
224
335
447
559
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00368
Hom.:
0
Bravo
AF:
0.0161
Asia WGS
AF:
0.0130
AC:
44
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Dec 09, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Cornelia de Lange syndrome 3 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.41
CADD
Benign
12
DANN
Benign
0.82
PhyloP100
0.20
PromoterAI
-0.017
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.2
Mutation Taster
=300/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148267784; hg19: chr10-112327476; API